ФАРМАКОГЕНЕТИЧНІ МАРКЕРИ ПРИ ТЕРАПІЇ ГОСТРОГО ЛІМФОБЛАСТНОГО ЛЕЙКОЗУ В ДІТЕЙ
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Despite major advances in therapy, the treatment of ALL remains a significant challenge. Therapeutic protocols are based on the use of combinations of chemotherapeutic drugs. While such combinations increase treatment effica...
Saved in:
| Date: | 2026 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
PH Akademperiodyka
2026
|
| Subjects: | |
| Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/574 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Experimental Oncology |